Evaluating Rapamycin Treatment in Alzheimer's Disease Using Positron Emission Tomography

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

December 11, 2024

Study Completion Date

January 17, 2025

Conditions

Alzheimer Disease

Interventions

DRUG

Sirolimus

7 mg taken once per week during 26 weeks.

Trial Locations (1)

Karolinska University Hospital Memory clinic, Solna

All Listed Sponsors

collaborator

Karolinska University Hospital

OTHER

lead

Karolinska Institutet

OTHER